Regional Analysis

Global Bio-implant Market- Regional Analysis

Among region, North America is expected to dominate the global bio-implant market over the forecast period, owing to North America 35.10% market share. High prevalence of cardiovascular diseases such as coronary heart disease, ischemic heart disease, arrhythmias, and others is expected to drive North America bio-implant market growth. For instance, according to an article published by Circulation Journal, a peer reviewed open access journal, in January 2021, the prevalence of cardiovascular diseases in adults above age of 20 years, in U.S., is around 49.2% (126.9 million in 2018), and increases with age in both males and females. The same source stated that the incidence of valvular heart disease is around 64 per 100, 000 person-years, with aortic stenosis (47.2%), mitral regurgitation (24.2%), and aortic regurgitation (18.0%) contributing most of the valvular diagnoses in 2018, in U.S.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa